In last trading session, Ventyx Biosciences Inc (NASDAQ:VTYX) saw 0.85 million shares changing hands with its beta currently measuring 0.48. Company’s recent per share price level of $4.85 trading at -$0.06 or -1.22% at ring of the bell on the day assigns it a market valuation of $341.92M. That closing price of VTYX’s stock is at a discount of -736.7% from its 52-week high price of $40.58 and is indicating a premium of 61.44% from its 52-week low price of $1.87. Taking a look at company’s average trading volume volume of 4.03 million if we extend that period to 3-months.

Ventyx Biosciences Inc (NASDAQ:VTYX) trade information

Upright in the red during last session for losing -1.22%, in the last five days VTYX remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $4.85 price level, adding 7.44% to its value on the day. Ventyx Biosciences Inc’s shares saw a change of 96.36% in year-to-date performance and have moved 23.41% in past 5-day. Ventyx Biosciences Inc (NASDAQ:VTYX) showed a performance of -1.02% in past 30-days.

Ventyx Biosciences Inc (VTYX) estimates and forecasts

Statistics highlight that Ventyx Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -66.41% of value to its shares in past 6 months, showing an annual growth rate of 22.73% while that of industry is 12.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -148.81% during past 5 years.

VTYX Dividends

Ventyx Biosciences Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.